Food & Function · 2021 · 43 citations · 36 references
Life SciencesNutritionNutritional SciencesMetabolomicsMicrobiome ResearchRenal PathophysiologyDiabetic Kidney DiseaseDiabetic NephropathyGut MicrobiomeGut MicrobiotaMicrobiome DysbiosisRenal DiseaseGut Microbiome DysbiosisGut Microbiota DysbiosisGut Microbiota EffectsImpaired Kidney FunctionIntestinal Microbiota EffectsMicrobiome-associated MetabolitesMicrobiota-barrier InteractionsNutrient Supplementation
for 8 weeks. Targeted metabolomics by GC-MS and 16S rRNA sequencing were implemented to determine short-chain fatty acids (SCFAs) and microbes. Further RNA sequencing analyses were performed to determine which differentially expressed genes were changed by PU. Compared with the DM model group, PU supplementation improved diabetic renal injury, ameliorated kidney architecture and function, and reshaped gut microbial ecology. Additionally, PU reversed HFD-induced gut barrier dysfunction, promoted cecal SCFA concentrations and inhibited serum lipopolysaccharide (LPS) and diamine oxidase (DAO) levels. Moreover, correlation analysis found that cecal SCFAs were significantly negatively correlated with inflammation-related genes in the kidney. The present results indicated that PU, a promising bioactive polyphenol, successfully improved diabetic renal injury, most likely through the gut-kidney axis.
36
The Gut Microbiota in Prediabetes and Diabetes: A Population-Based Cross-Sectional Study
Hao Wu, Valentina Tremaroli, Caroline Schmidt et al. · Cell Metabolism · 2020 · 526 citations · Full text
Yan Jun Li, Xiaochen Chen, Tony Kwan et al. · Journal of the American Society of Nephrology · 2020 · 355 citations · Full text